Cargando…

Metformin in breast cancer - an evolving mystery

Metformin, a diabetes drug with well-established side effect and safety profiles, has been widely studied for its anti-tumor activities in a number of cancers, including breast cancer. But its mechanism of action in the clinical arena remains elusive. In a window of opportunity trial of metformin in...

Descripción completa

Detalles Bibliográficos
Autores principales: Camacho, Laura, Dasgupta, Atreyi, Jiralerspong, Sao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4480505/
https://www.ncbi.nlm.nih.gov/pubmed/26111812
http://dx.doi.org/10.1186/s13058-015-0598-8